News and Opinions

By Susan Buckles - Mayo Clinic During clinical rotations in medical school, Kianna Nguyen encountered many patients with liver failure and was struck by a grim reality: Their only hope was a transplant. The shortage of donor organs and therapeutic options was at once...

By Drug Target Review Immunotherapy, the promising therapy which harnesses the power of the body’s immune response to target cancer cells, may be advanced by a new minifridge bioreactor developed by researchers at Washington State University. This bioreactor can...

By UNSW Newsroom The 'Trpzip' material will reform after being squished, fractured, or after being expelled from a syringe. Photo: UNSW Sydney Scientists at UNSW Sydney have created a new material that could change the way human tissue can be grown in the lab and used...

By SciTechDaily A study from the Ann & Robert H. Lurie Children’s Hospital of Chicago discovered that directly injecting neonatal mesenchymal stem cells, sourced from heart tissue usually discarded during surgery, reduces intestinal inflammation and promotes wound...

By Angela Spivey - Duke University School of Medicine Scientists and clinicians at the Duke University School of Medicine have discovered new details about how lung tissue heals after injury caused by toxins such as air pollution or cigarette smoke. The researchers...

By Waterloo News People who have experienced significant muscle damage have new hope thanks to Evolved.Bio, a startup that has developed innovative technology that can regenerate muscle tissue in a highly effective way. Other biotech companies use natural or synthetic...

by Felix Myhill - RegMedNet Researchers at the University of California, Los Angeles (UCLA; CA, USA) have produced safe and effective allogeneic immune cells that one day may be mobilized to combat cancer. Allogeneic cell therapies differ from autologous cell...

By Mayo Clinic's Discovery's Edge Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The team also found...

By Gina Kolata – The New York Times The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. Regulators in Britain on Thursday approved the first treatment derived from CRISPR, the...

By News Medical Life Sciences Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in...

By Andrew Schulman - Technology Networks Why do we need allogeneic therapies when autologous therapies have enjoyed such success? The lessons learned from the development and manufacture of autologous cell therapies are helping lay a solid groundwork for the high...

By Meghan Bartels - Scientific American Scientists have just achieved a milestone in stem-cell biology after creating a monkey from two embryos. And proof of the achievement, perhaps unnervingly, showed up in the infant primate’s eerie green glow. Although research...

by Sarah C.P. Williams, UCLA  - Phys.org News Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA are one step closer to developing stem cell therapies to regenerate skeletal muscle in humans. Working in mice, the...

by Tristan Epps - Penn Medicine News Ben Stanger, MD, PhD is a practicing Gastroenterologist at Penn Medicine. He is also the Hanna Wise Professor in Cancer Research and professor of Medicine and Cell and Developmental biology at the University of Pennsylvania....

Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia (RPD) with reasonably high confidence during a patient's first clinical visit. This scoring criteria may allow physicians to...

By Reuters News Oct 31 (Reuters) - A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval. If the...

By Japan Times A Japanese medical institution, in a first for the country, will seek government approval for using embryonic stem cells as a regenerative medicine product to treat babies with a severe liver ailment, sources close to the matter said Monday. The step...

By Kyushu University Fukuoka, Japan – Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice. These findings, published on October 10 in PNAS, suggest that...